PE Firms & Medical Practices: Benefits & Risks | Medscape

The steady creep of private equity into American healthcare continues, with ambulatory surgical centers (ASCs) becoming a particularly attractive target. While the influx of capital can sometimes modernize facilities and expand access, a growing body of reporting suggests a more complex picture – one where cost-cutting measures and a focus on profit can subtly reshape the patient experience and, potentially, the quality of care. The phenomenon, increasingly referred to as the “golden handcuffs” of private equity, is prompting scrutiny from both medical professionals and regulators.

The Rise of Financial Investment in Medical Practices

The trend isn’t limited to surgical centers. Private equity firms have been steadily acquiring medical practices across a range of specialties, from dermatology to ophthalmology. An analysis by the American Medical Association revealed that 6.5% of physician practices now have some form of private equity backing, a figure that has been rapidly increasing in recent years. As Medscape reported in January 2026, this expansion extends far beyond ophthalmology, impacting a broad spectrum of medical fields. The sector has seen an “explosion” with “more than 18,000 private equity funds” now involved, according to reporting from December 2025.

The appeal for private equity is straightforward: healthcare is a relatively stable and predictable market, shielded from many of the economic fluctuations that affect other industries. ASCs, in particular, are seen as lucrative investments due to their potential for high margins and relatively low regulatory hurdles compared to traditional hospitals. The business model often involves standardizing procedures, streamlining operations, and negotiating favorable contracts with insurance companies – all strategies aimed at maximizing profitability.

What Does This Mean for Patients and Physicians?

The impact of private equity ownership on patient care is a subject of ongoing debate. Proponents argue that the infusion of capital can lead to improvements in facilities, technology, and efficiency, ultimately benefiting patients. However, critics raise concerns about potential cost-cutting measures that could compromise quality of care. These concerns include increased pressure to perform more procedures, reduced staffing levels, and a shift towards prioritizing profitable services over those that are less lucrative.

Dr. Zhu, a primary care physician in Portland, Oregon, who has researched the rise of private-equity investment in medical practices, highlights the subtle but significant changes that can occur. While not directly quoted in the Medscape reporting, her research underscores the potential for a shift in priorities, where financial considerations may outweigh clinical judgment. This can manifest in various ways, such as limitations on the time physicians can spend with patients or pressure to adhere to standardized treatment protocols, even when they may not be in the patient’s best interest.

The “golden handcuffs” metaphor refers to the financial incentives offered to physicians to remain with a practice after it’s acquired by a private equity firm. These incentives can include lucrative contracts, bonuses, and stock options, creating a situation where physicians may feel compelled to prioritize the financial interests of the firm over their own professional autonomy or the needs of their patients. It’s a complex dynamic, as many physicians are burdened with significant student loan debt and face increasing financial pressures themselves.

The Role of UnitedHealth and Larger Healthcare Systems

The involvement of large healthcare systems like UnitedHealth in the acquisition of ASCs adds another layer of complexity to the issue. Medscape’s December 2025 report notes that despite the growth in private equity funds, UnitedHealth remains a significant player in the ASC market. This raises questions about potential conflicts of interest, as these large systems may have an incentive to steer patients towards facilities they own, regardless of whether they offer the best or most appropriate care.

Understanding the Financial Mechanics

Private equity firms typically acquire medical practices by taking on debt, using the practice’s future earnings to repay the loan. This model relies on increasing revenue and reducing costs to generate sufficient cash flow. While some cost-cutting measures may be legitimate efficiency improvements, others can have negative consequences for patient care. For example, reducing staffing levels or using lower-quality supplies can save money in the short term but may compromise the quality of services provided.

The financial structure also creates a timeline for exit. Private equity firms typically hold investments for 3-7 years before selling them to another investor or taking them public. This short-term focus can incentivize firms to prioritize maximizing profits over long-term sustainability or investment in infrastructure.

What Comes Next: Increased Scrutiny and Potential Regulation

The growing concerns about the impact of private equity on healthcare are prompting increased scrutiny from regulators and policymakers. The Federal Trade Commission (FTC) is reportedly investigating several private equity acquisitions of medical practices, focusing on potential antitrust violations and concerns about patient harm. There’s also growing discussion about the need for greater transparency in private equity ownership and increased regulation of the industry.

The American Medical Association has called for greater oversight of private equity investment in healthcare, advocating for policies that would protect patient access to care and ensure that financial incentives do not compromise quality. These policies could include requirements for greater disclosure of private equity ownership, restrictions on certain types of acquisitions, and increased enforcement of antitrust laws.

For patients, it’s important to be informed and inquire questions about the ownership structure of their healthcare providers. While private equity ownership doesn’t automatically mean that care will be compromised, it’s essential to be aware of the potential risks and advocate for their own best interests. Consulting with multiple providers and seeking second opinions can also help ensure that they receive the best possible care.

The situation remains fluid, and the long-term impact of private equity on healthcare is still unfolding. Continued monitoring, research, and policy debate will be crucial to ensuring that the pursuit of profit does not come at the expense of patient well-being.